2002
DOI: 10.1590/s0037-86822002000200008
| View full text |Cite
|
Sign up to set email alerts
|

Abstract: In August/1999, a group of 14 adults from the staff of a private hospital in Contagem -- Minas Gerais State, Brazil, received unintentionally a 25 times concentrated dose of the 17-DD yellow fever vaccine (Bio-Manguinhos), due to a mistake at the reconstitution step. All patients were clinically and laboratorially evaluated at days 5, 13 and 35 post vaccination. Frequency of side effects and clinical observations of this group of individuals were not different from the observed in recipients immunized with nor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0
1

Year Published

2008
2008
2023
2023

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 8 publications
(4 reference statements)
0
6
0
1
Order By: Relevance
“…In a dose-response study viremias by virus isolation, qRT-PCR, and clinical reactogenicity were statistically similar across the different study arms, with deescalating doses from 27,476 IU (approximately 52,000 PFU, the usual dose) to 31 IU (approximately 60 PFU) 32 Mass vaccination campaigns include errors administering vaccines in doses from 10 times to 25 times the recommended dose (n D 163), but there were no serious adverse events. 13,33,34 Moreover, in BioManguinhos/Fiocruz, the release titers are verified for all lots and have been around 70,000 PFU/human dose and within narrow limits of variation across different lots along the last decades, showing a very consistent and homogeneous production. So, this hypothesis seems untenable.…”
Section: Virus Dosementioning
confidence: 83%
“…In a dose-response study viremias by virus isolation, qRT-PCR, and clinical reactogenicity were statistically similar across the different study arms, with deescalating doses from 27,476 IU (approximately 52,000 PFU, the usual dose) to 31 IU (approximately 60 PFU) 32 Mass vaccination campaigns include errors administering vaccines in doses from 10 times to 25 times the recommended dose (n D 163), but there were no serious adverse events. 13,33,34 Moreover, in BioManguinhos/Fiocruz, the release titers are verified for all lots and have been around 70,000 PFU/human dose and within narrow limits of variation across different lots along the last decades, showing a very consistent and homogeneous production. So, this hypothesis seems untenable.…”
Section: Virus Dosementioning
confidence: 83%
“…The current study has not enough power to define if lower yellow fever vaccine doses may be followed by a decrease in serious adverse events, such as vaccine-associated viscerotropic disease. On the other hand, information about the effect of large doses administered inadvertently is scant, based in few individuals and does not permit conclusions 29 , 30 …”
Section: Discussionmentioning
confidence: 99%
“…The infectivity assay underestimates the number of genome equivalents (measured by RT-PCR) by approximately 1000-fold [108]. Inadvertant overdose of YF vaccine has occurred occasionally, without any known adverse effects [122], and none would be expected based on the knowledge of virus-host interactions. The problem may, in fact, be the reverse -the administration of very low doses could potentially be associated with high, delayed or prolonged viremia and potentially increase the risk of neuroinvasion.…”
Section: Relationship Of Vaccine Dose To Safety and Efficacymentioning
confidence: 99%